Risks include urinary incontinence, erectile dysfunction, infection, and bleeding. These risks vary depending on the patient’s overall health and the surgical technique used.

The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

It measures the current blood glucose level at any time of the day.

No, fasting is not required for this test.

Results are usually available within a few hours, allowing for prompt medical assessment.

It helps diagnose diabetes, monitor glucose control, and assess emergency situations related to blood sugar levels.